These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 10994550
1. Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors. Grotzer MA, Janss AJ, Phillips PC, Trojanowski JQ. Klin Padiatr; 2000; 212(4):196-9. PubMed ID: 10994550 [Abstract] [Full Text] [Related]
5. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91. Rutkowski S, von Bueren A, von Hoff K, Hartmann W, Shalaby T, Deinlein F, Warmuth-Metz M, Soerensen N, Emser A, Bode U, Mittler U, Urban C, Benesch M, Kortmann RD, Schlegel PG, Kuehl J, Pietsch T, Grotzer M. Clin Cancer Res; 2007 May 01; 13(9):2651-7. PubMed ID: 17473196 [Abstract] [Full Text] [Related]
6. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion. Marchetti D, Mrak RE, Paulsen DD, Sinnappah-Kang ND. J Exp Clin Cancer Res; 2007 Mar 01; 26(1):5-23. PubMed ID: 17550129 [Abstract] [Full Text] [Related]
8. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma. Grotzer MA, von Hoff K, von Bueren AO, Shalaby T, Hartmann W, Warmuth-Metz M, Emser A, Kortmann RD, Kuehl J, Pietsch T, Rutkowski S. Klin Padiatr; 2007 Apr 01; 219(6):312-7. PubMed ID: 18050040 [Abstract] [Full Text] [Related]
9. Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system. Washiyama K, Muragaki Y, Rorke LB, Lee VM, Feinstein SC, Radeke MJ, Blumberg D, Kaplan DR, Trojanowski JQ. Am J Pathol; 1996 Mar 01; 148(3):929-40. PubMed ID: 8774147 [Abstract] [Full Text] [Related]
10. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors. Bobola MS, Finn LS, Ellenbogen RG, Geyer JR, Berger MS, Braga JM, Meade EH, Gross ME, Silber JR. Clin Cancer Res; 2005 Oct 15; 11(20):7405-14. PubMed ID: 16243814 [Abstract] [Full Text] [Related]
11. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome. Butturini AM, Jacob M, Aguajo J, Vander-Walde NA, Villablanca J, Jubran R, Erdreich-Epstein A, Marachelian A, Dhall G, Finlay JL. Cancer; 2009 Jul 01; 115(13):2956-63. PubMed ID: 19402050 [Abstract] [Full Text] [Related]
12. Prognostic significance of Ki-67 (MIB-1) proliferation index in childhood primitive neuroectodermal tumors of the central nervous system. Grotzer MA, Geoerger B, Janss AJ, Zhao H, Rorke LB, Phillips PC. Med Pediatr Oncol; 2001 Feb 01; 36(2):268-73. PubMed ID: 11452934 [Abstract] [Full Text] [Related]
13. Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas. Phi JH, Kim JH, Eun KM, Wang KC, Park KH, Choi SA, Kim YY, Park SH, Cho BK, Kim SK. J Neurosurg Pediatr; 2010 Jun 01; 5(6):608-14. PubMed ID: 20515335 [Abstract] [Full Text] [Related]
14. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. Gajjar A, Hernan R, Kocak M, Fuller C, Lee Y, McKinnon PJ, Wallace D, Lau C, Chintagumpala M, Ashley DM, Kellie SJ, Kun L, Gilbertson RJ. J Clin Oncol; 2004 Mar 15; 22(6):984-93. PubMed ID: 14970185 [Abstract] [Full Text] [Related]
15. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines. Stephan H, Zakrzewski JL, Bölöni R, Grasemann C, Lohmann DR, Eggert A. Pediatr Blood Cancer; 2008 Feb 15; 50(2):218-22. PubMed ID: 17973327 [Abstract] [Full Text] [Related]
16. A clinicobiological model predicting survival in medulloblastoma. Ray A, Ho M, Ma J, Parkes RK, Mainprize TG, Ueda S, McLaughlin J, Bouffet E, Rutka JT, Hawkins CE. Clin Cancer Res; 2004 Nov 15; 10(22):7613-20. PubMed ID: 15569993 [Abstract] [Full Text] [Related]
17. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors. Bruch LA, Hill DA, Cai DX, Levy BK, Dehner LP, Perry A. Hum Pathol; 2001 Feb 15; 32(2):156-62. PubMed ID: 11230702 [Abstract] [Full Text] [Related]